{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:04:42Z","timestamp":1781769882813,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ejso.2023.107073","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T03:15:01Z","timestamp":1695266101000},"page":"107073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Is hepatectomy feasible for hepatocellular carcinoma patients with clinically significant portal hypertension and beyond the Milan criteria?"],"prefix":"10.1016","volume":"49","author":[{"given":"Zhan","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangde","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2023.107073_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.ejso.2023.107073_bib2","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2023.107073_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2023.107073_bib4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.ejso.2023.107073_bib5","first-page":"112","article-title":"Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)","volume":"28","year":"2020","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.ejso.2023.107073_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/lt.24977","article-title":"Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan Criteria (Barcelona Clinic Liver Cancer extended criteria)","volume":"24","author":"Llovet","year":"2018","journal-title":"Liver Transplant"},{"key":"10.1016\/j.ejso.2023.107073_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.21037\/tgh.2017.08.02","article-title":"Living donor liver transplantation for hepatocellular cancer: an (almost) exclusive Eastern procedure?","volume":"2","author":"Pinheiro","year":"2017","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2023.107073_bib8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/hep.29485","article-title":"Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: a systematic review and meta-analysis","volume":"67","author":"Kulik","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2023.107073_bib9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1159\/000507887","article-title":"The real impact of bridging or downstaging on survival outcomes after liver transplantation for hepatocellular carcinoma","volume":"9","author":"Lee","year":"2020","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ejso.2023.107073_bib10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S1470-2045(20)30224-2","article-title":"Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b\/3 trial","volume":"21","author":"Mazzaferro","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2023.107073_bib11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.cgh.2017.11.037","article-title":"Excellent outcomes of liver transplantation following down-staging of hepatocellular carcinoma to within milan criteria: a multicenter study","volume":"16","author":"Mehta","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2023.107073_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.clinre.2015.07.008","article-title":"Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"40","author":"Chen","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.ejso.2023.107073_bib13","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1200\/JCO.2012.42.9936","article-title":"Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial","volume":"31","author":"Peng","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2023.107073_bib14","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1002\/cncr.25314","article-title":"Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization","volume":"116","author":"Morimoto","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2023.107073_bib15","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0016-5085(96)70070-7","article-title":"Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure","volume":"111","author":"Bruix","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejso.2023.107073_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1586\/egh.12.83","article-title":"Assessing portal hypertension in liver diseases","volume":"7","author":"Berzigotti","year":"2013","journal-title":"Expet Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2023.107073_bib17","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/annonc\/mdy510","article-title":"Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Vogel","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2023.107073_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European association for the study of the liver","volume":"35","author":"Bruix","year":"2001","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.ejso.2023.107073_bib19","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2023.107073_bib20","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/bjs.8861","article-title":"Intraoperative portal venous pressure and long-term outcome after curative resection for hepatocellular carcinoma","volume":"99","author":"Hidaka","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2023.107073_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hpb.2018.07.005","article-title":"Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"21","author":"Liu","year":"2019","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.ejso.2023.107073_bib22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.ejso.2023.107073_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108755","article-title":"Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertension","volume":"9","author":"Zhong","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejso.2023.107073_bib24","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1097\/SLA.0000000000003496","article-title":"Intraoperative increase of portal venous pressure is an immediate predictor of posthepatectomy liver failure after major hepatectomy: a prospective study","volume":"274","author":"Bogner","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2023.107073_bib25","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2023.107073_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1365-182X(17)30755-4","article-title":"The Brisbane 2000 terminology of liver anatomy and resections","volume":"2","author":"Pang","year":"2000","journal-title":"HPB"},{"key":"10.1016\/j.ejso.2023.107073_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2023.107073_bib28","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/01.sla.0000189131.90876.9e","article-title":"The \"50-50 criteria\" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy","volume":"242","author":"Balzan","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2023.107073_bib29","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jamcollsurg.2006.12.032","article-title":"Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy","volume":"204","author":"Mullen","year":"2007","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2023.107073_bib30","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.ejso.2023.107073_bib31","article-title":"Portal hypertension and variceal bleeding in patients with liver cancer: evidence gaps for prevention and management","author":"Allaire","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2023.107073_bib32","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/jhbp.124","article-title":"Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"21","author":"Choi","year":"2014","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.ejso.2023.107073_bib33","first-page":"310","article-title":"Expert consensus on clinical diagnosis and treatment of portal hypertension with hepatocellular carcinoma (2022)","volume":"60","year":"2022","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"10.1016\/j.ejso.2023.107073_bib34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1245\/s10434-012-2513-1","article-title":"A\u00a0systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability","volume":"20","author":"Rodr\u00edguez-Per\u00e1lvarez","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2023.107073_bib35","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S1470-2045(15)00198-9","article-title":"Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"16","author":"Bruix","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2023.107073_bib36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1724600819834306","article-title":"Prognostic markers affecting the early recurrence of hepatocellular carcinoma with liver cirrhosis after curative resection","volume":"34","author":"Kim","year":"2019","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.ejso.2023.107073_bib37","article-title":"The influence of liver resection on intrahepatic tumor growth","author":"Brandt","year":"2016","journal-title":"J\u00a0Vis Exp"},{"key":"10.1016\/j.ejso.2023.107073_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10585-013-9604-7","article-title":"Tumour growth stimulation following partial hepatectomy in mice is associated with increased upregulation of c-Met","volume":"31","author":"Harun","year":"2014","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.ejso.2023.107073_bib39","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1089\/lap.2020.0408","article-title":"Laparoscopic liver surgery: what are the advantages in patients with cirrhosis and portal hypertension? Systematic review and meta-analysis with personal experience","volume":"30","author":"Coletta","year":"2020","journal-title":"J\u00a0Laparoendosc Adv Surg Tech"},{"key":"10.1016\/j.ejso.2023.107073_bib40","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.12998\/wjcc.v9.i11.2419","article-title":"Current status of radical laparoscopy for treating hepatocellular carcinoma with portal hypertension","volume":"9","author":"Shen","year":"2021","journal-title":"World J Clin Cases"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323007114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323007114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:49:49Z","timestamp":1760060989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798323007114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0748798323007114"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2023.107073","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is hepatectomy feasible for hepatocellular carcinoma patients with clinically significant portal hypertension and beyond the Milan criteria?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2023.107073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107073"}}